Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers and Candidacy for Convalescent Plasma Therapy/Prophylaxis

NCT04334876 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT04334876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers and Candidacy for Convalescent Plasma Therapy/Prophylaxis
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2020
Completion date
January 1, 2021
Enrollment
571 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2